Sumitomo Dainippon Pharma Co., Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sumitomo Dainippon Pharma Co., Ltd.
Kyorin, Eisai build on earlier OAB deal to team on vibegron. Plus deals involving Piramal/Hemmo, ImmuneOncia/3D Medicines, Kyowa Kirin/Cerecor, Simcere/Kazia, Nippon Shinyaku/Menarini, Tarsus/LianBio
Poxel’s potential first-in-class diabetes therapy, imeglimin, could be approved in Japan this year, and a new partner is being sought for the EU and US – events that would transform the outlook for the decade-old Merck Serono spin-out.
Japanese firm’s recent decision to halt development of its lead oncology asset, gained through a multi-billion-dollar acquisition where it was the main attraction, not only has a financial cost but may prompt more strategic deal-making.
Private Company Edition: Venture capital mega-rounds continue a brisk pace with machine learning-based drug discovery firm insitro and gene therapy developer Graphite Bio among recent $100m-plus deals. Also, Argobio raised €50m to fund five start-ups in Europe.
- Other Names / Subsidiaries
- Adagio Pharmaceuticals Ltd.
- Altavant Sciences
- Boston Biomedical, Inc.
- Boston Biomedical Pharma, Inc.
- Cannasat Therapeutics Inc.
- Cynapsus Therapeutics, Inc.
- Dainippon Sumitomo Pharma Co., Ltd.
- Dainippon Sumitomo Pharma Europe Ltd.
- DS Pharma Promo Co., Ltd,
- Elevation Pharmaceuticals, Inc.
- Enzyvant Therapeutics, Inc.
- Enzyvant Sciences, Ltd.
- Myovant Sciences Ltd
- Myovant Sciences GmbH
- Myovant Sciences, Inc.
- Oryx Pharmaceuticals Inc.
- SB Bioscience Co., Ltd.
- Spirovant Sciences
- Sumitomo Chemical Co., Ltd.
- Sumitomo Dainippon Pharma America, Inc. (formerly Dainippon Sumitomo Pharma America Holdings, Inc.)
- Sumitomo Dainippon Pharma Oncology, Inc.
- Sumitomo Pharmaceuticals America
- Sumitomo Pharmaceuticals (Suzhou) Co., Ltd.
- Sumitovant Biopharma
- Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.)
- Sunovion Pharmaceuticals Europe Ltd.
- Sunovion Respiratory Development Inc.
- Tolero Pharmaceuticals, Inc.
- Urovant Sciences, Inc.
- Sumitomo Pharmaceuticals Taiwan Co., Ltd.